Chloro-and hydroxo-palladium(II) complexes with an imidazole-based scorpionate ligand bis(1-methylimidazolyl)methylphenylborate, [B(Im N-Me ) 2 MePh] -(= L Ph ), have been synthesized. Reaction of a lithium salt of L Ph with [PdCl 2 (NCPh) 2 ] yields a miscellaneous mixture involving a homoleptic complex [Pd(L Ph ) 2 ]. Replacement of the neutral ligand (benzonitrile) in the starting material with pyridine leads to the desired chloride complex 1. X-ray crystallographic analysis reveals the formula of 1 to be [PdCl(L Ph )(py)] with a square-planar palladium(II) center
IntroductionPoly(pyrazolyl)borates, [B(pz R ) n X 4-n ] -(n = 2-4; R = substituent groups on the pyrazole ring; X = H, akyl, phenyl, etc.), have been extensively utilized in various coordination compounds ranging from bioinorganic models to organometallics. [1,2] In addition to these authentic "scorpionate" ligands, interests in other borate-based chelating ligands with N-, [3-6] P-, [7] S- [8] and C-donors [9] have been growing in recent years. As N-donating ligands, azoles such as pyridines, [4] oxazolines, [5] and imidazoles [6] have been employed instead of pyrazoles. In such Ndonating ligands, except for the poly(pyrazolyl)borates, the azoles are connected to a boron atom through carbon-boron bonds. The higher covalency of B-C linkages makes such species resistant to hydrolytic degradation. Consequently, these new types of scorpionate ligands are expected to be extensively applied to various organometallic and biomimetic catalysts.Many complexes of group 10 elements with a family of poly(pyrazolyl)borates including hydrotris(pyrazolyl)borates (= Tp R ) have been reported thus far. In Pd II complexes, Tp R behaves as bidentate ligand, because Pd II favors a square-planar geometry forming metastable 16especies. [10][11][12][13] Therefore, bidentate 4edonating ligands would be suitable to obtain Pd II complexes. In fact, bis(pyrazolyl)borates (= Bp R ) have been employed as supporting ligands for Pd II , and a few such molecular structures are known. [10,14] Our developed imidazole-based -1 [a]